WERE RANDOMIZED in Croatian translation

• randomizirano je
• su bili randomizirani
• bilo randomizirano
• su randomizirana

Examples of using Were randomized in English and their translations into Croatian

In this trial, patients were randomized to receive 5 monthly injections of 15mg/kg of liquid palivizumab(N=3306)
U ovom ispitivanju bolesnici su randomizirani i dobivali su 5 mjesečnih injekcija od 15 mg/kg tekućeg palivizumaba(N=3306)

Overall, 6068 patients were randomized 1:1 to either placebo
Svekupno, 6068 bolesnika bilo je randomizirano 1:1 na placebo

Patients were randomized(2:1) to receive blinded treatment with entecavir 0.015 mg/kg up to 0.5 mg/day(N 120) or placebo N 60.
Bolesnici su randomizirani(2:1) da primaju slijepo liječenje entekavirom u dozi od 0, 015 mg/kg do najviše 0, 5 mg/dan(N 120) ili placebo N 60.

Patients were randomized in a 1:1 fashion to treatment with either bosutinib 500 mg once daily or imatinib 400 mg once daily.
Bolesnici su randomizirani na način 1:1 za liječenje ili bosutinibom 500 mg jedanput dnevno ili imatinibom 400 mg jedanput dnevno.

Patients were randomized to stay on their treatment at the time of enrollment
Bolesnici su randomizirani tako da su u trenutku uključivanja nastavili s liječenjem

Study I patients were randomized to receive abatacept 2
U Ispitivanju I bolesnici su randomizirani da tijekom 12 mjeseci primaju abatacept u dozi od 2

Study V patients were randomized to receive this same fixed dose of abatacept
U Ispitivanju V bolesnici su randomizirani tako da su tijekom 6 mjeseci primali abatacept u istoj toj fiksnoj dozi,

Subjects were randomized in a 2:1 ratio and stratified based on cirrhosis/fibrosis and baseline HCV-RNA< 800,000 IU/mL vs.≥ 800,000 IU/mL.
Ispitanici su randomizirani u omjeru 2:1 i stratificirani na temelju ciroze/fibroze i početne vrijednosti HCV-RNK< 800 000 IU/ml naspram ≥ 800 000 IU/ml.

A total of 96 patients, aged 12 to 43 years, were randomized in the intent-to-treat population.
Ukupno 96 bolesnika u dobi od 12 do 43 godine bilo je randomizirano u populaciji predviđenoj za liječenje ITT.

patients with an IOP≥19 mmHg were randomized to receive added treatment with brinzolamide or timolol.
bolesnici s IOT ≥19 mmHg su randomizirani na primanje dodatne terapije brinzolamida ili timolola.

Seventy-seven men with facial acne scored 2-3 according to Investigator's Global Assessment(IGA) were randomized to receive placebo cream(n 15),
Sedamdeset i sedam muškaraca s aknama lica 2-3 prema Globalnoj procjeni istraživača(IGA) randomizirano je za primanje placebo kreme(n 15)

In both studies, patients were randomized 2:1 to apremilast 30 mg BID
U oba ispitivanja bolesnici su bili randomizirani u omjeru 2:1 na apremilast od 30 mg BID

who had recently received chemotherapy) were randomized 1:1 to trivalent Fluenz or placebo.
koji su nedavno primili kemoterapiju) randomizirano je 1:1 prema primanju trovalentnog cjepiva Fluenz ili placeba.

Of 131 patients who responded to ustekinumab induction, and were randomized to the placebo group at the start of the maintenance study,
Od 131 bolesnika koji su odgovorili na uvođenje ustekinumaba i koji su bili randomizirani u placebo skupinu na početku ispitivanja terapije održavanja,

Patients were randomized in a 3:1:1 ratio to receive ipilimumab 3 mg/kg+ an investigational gp100 peptide vaccine(gp100),
Bolesnici su bili randomizirani u omjeru 3:1:1 u skupine koje su primale ipilimumab u dozi od 3 mg/kg+ ispitivano gp100 peptidno cjepivo(gp100),

Patients were randomized to receive either pegylated interferon alfa-2b(100
Bolesnici su bili randomizirani tako da su primali pegilirani interferon alfa-2b(100

Following this dose conversion, 91 study patients(mean age: 64.1 years; 75% male patients) were randomized to receive Numient followed by pre- study LCE
Nakon ove konverzije doze randomiziran je 91 bolesnik iz ispitivanja(srednja vrijednost dobi je 64,

In SC-I, 1262 patients were randomized 1:1 to receive tocilizumab subcutaneous 162 mg every week
U ispitivanju SC-I, 1262 bolesnika randomizirana su u omjeru 1:1 za liječenje tocilizumabom u supkutanoj dozi od 162 mg jedanput tjedno

20 healthy male subjects were randomized to receive a single subcutaneous dose of 400 mg of certolizumab pegol or placebo.
20 zdravih muških ispitanika je randomizirano za primanje jednokratne supkutane doze 400 mg certolizumabpegola ili placeba.

doxorubicin regimens), were randomized to receive either Akynzeo(n=309)
oksaliplatinom i doksorubicinom) bili su randomizirani i primali su